Evidence map›Paper›PMID 31635394›Full record

ArticleSensors (Basel, Switzerland)2019

Commercial Devices-Based System Designed to Improve the Treatment Adherence of Hypertensive Patients.

Vandermi João da Silva, Vinicius da Silva Souza, Robson Guimarães da Cruz, Juliana Mesquita Vidal Martinez de Lucena, Nasser Jazdi, Vicente Ferreira de Lucena Junior

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve.Journal of cardiovascular development and disease · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Vandermi João da SilvaFederal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. vandermisilva@gmail.com.
Vinicius da Silva SouzaFederal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. souzavinicius1993@gmail.com.
Robson Guimarães da CruzFederal University of Amazonas, UFAM-PPGEE, Manaus-Amazonas 69067-005, Brazil. robsoncruz.ufam@gmail.com.
Juliana Mesquita Vidal Martinez de LucenaFederal Institute of Amazonas, IFAM-CMC, Amazonas, Brazil. juliana.lucena@ifam.edu.br.
Nasser JazdiInstitute of Industrial Automation and Software Systems, The University of Stuttgart, 70174 Stuttgart, Germany. Nasser.Jazdi@ias.uni-stuttgart.de.
Vicente Ferreira de Lucena JuniorFederal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. vicente@ufam.edu.br.
Universidade Federal do Amazonas · BRInstituto Federal do Amazonas · BRUniversity of Stuttgart · DE

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 2018Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado do Amazonas 2017Samsung Electronics of Amazonia Ltda 004 Ceteli/Ufam
6 · The paper itself

Abstract

This paper presents an intelligent system designed to increase the treatment adherence of hypertensive patients. The architecture was developed to allow communication among patients, physicians, and families to determine each patient's rate assertion of medication intake time and their self-monitoring of blood pressure. Concerning the medication schedule, the system is designed to follow a predefined prescription, adapting itself to undesired events, such as mistakenly taking medication or forgetting to take medication on time. When covering the blood pressure measurement, it incorporates best medical practices, registering the actual values in recommended frequency and form, trying to avoid the known "white-coat effect." We assume that taking medicine precisely and measuring blood pressure correctly may lead to good adherence to the treatment. The system uses commercial consumer electronic devices and can be replicated in any home equipped with a standard personal computer and Internet access. The resulting architecture has four layers. The first is responsible for adding electronic devices that typically exist in today's homes to the system. The second is a preprocessing layer that filters the data generated from the patient's behavior. The third is a reasoning layer that decides how to act based on the patient's activities observed. Finally, the fourth layer creates messages that should drive the reactions of all involved actors. The reasoning layer takes into consideration the patient's schedule and medication-taking activity data and uses implicit algorithms based on the J48, RepTree, and RandomTree decision tree models to infer the adherence. The algorithms were first adjusted using one academic machine learning and data mining tool. The system communicates with users through smartphones (anytime and anywhere) and smart TVs (in the patient's home) by using the 3G/4G and WiFi infrastructure. It interacts automatically through social networks with doctors and relatives when changes or mistakes in medication intake and blood pressure mean values are detected. By associating the blood pressure data with the history of medication intake, our system can indicate the treatment adherence and help patients to achieve better treatment results. Comparisons with similar research were made, highlighting our findings.

Indexed as

Medication AdherenceAlgorithmsAntihypertensive AgentsBlood Pressure DeterminationCloud ComputingHumansHypertensionInternet AccessSmartphoneWearable Electronic DevicesAntihypertensive Agentsambient intelligenceassisted livinghealth information managementmedical expert systemsmedical treatmentsmart homes

Identifiers

PMID31635394
PMCPMC6832274
OpenAlexW2980552122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.